Revenio Group Oyj (OTCMKTS:REVXF – Get Free Report) saw a significant growth in short interest in June. As of June 30th, there was short interest totaling 51,445 shares, a growth of 136.9% from the June 15th total of 21,713 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.
Revenio Group Oyj Stock Performance
OTCMKTS:REVXF remained flat at $16.41 during mid-day trading on Tuesday. The company has a fifty day moving average of $17.07 and a 200 day moving average of $19.87. Revenio Group Oyj has a 1 year low of $16.41 and a 1 year high of $16.54.
Revenio Group Oyj Company Profile
Revenio Group Oyj is a Finland‐based medical technology company specializing in ophthalmic diagnostic instruments. The company’s core business centers on the design, manufacture and sales of intraocular pressure (IOP) measurement devices that support glaucoma screening, diagnosis and long‐term patient monitoring. Utilizing patented rebound tonometry technology, Revenio’s tonometers provide rapid, non-invasive IOP readings without the need for topical anesthesia, making them well‐suited for both clinical and home settings.
Revenio’s product portfolio is anchored by the Icare® family of tonometers, which includes the Icare PRO for clinical use and the Icare HOME for patient self-monitoring.
Featured Stories
- Five stocks we like better than Revenio Group Oyj
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for Revenio Group Oyj Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revenio Group Oyj and related companies with MarketBeat.com's FREE daily email newsletter.
